Mark V. Jarowenko

926 total citations
26 papers, 760 citations indexed

About

Mark V. Jarowenko is a scholar working on Surgery, Pediatrics, Perinatology and Child Health and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Mark V. Jarowenko has authored 26 papers receiving a total of 760 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Surgery, 8 papers in Pediatrics, Perinatology and Child Health and 8 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Mark V. Jarowenko's work include Renal Transplantation Outcomes and Treatments (8 papers), Organ Donation and Transplantation (5 papers) and Bladder and Urothelial Cancer Treatments (5 papers). Mark V. Jarowenko is often cited by papers focused on Renal Transplantation Outcomes and Treatments (8 papers), Organ Donation and Transplantation (5 papers) and Bladder and Urothelial Cancer Treatments (5 papers). Mark V. Jarowenko collaborates with scholars based in United States. Mark V. Jarowenko's co-authors include Michael F. Sarosdy, Joel Sheinfeld, Brent A. Blumenstein, Mark S. Soloway, M’Liss A. Hudson, George W. Adams, Stuart M. Flechner, Ralph W. deVere White, P F Schellhammer and Ronald H. Kerman and has published in prestigious journals such as Annals of Surgery, The Journal of Urology and American Journal of Kidney Diseases.

In The Last Decade

Mark V. Jarowenko

25 papers receiving 690 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark V. Jarowenko United States 12 420 161 141 95 95 26 760
Paramit Chowdhury United Kingdom 13 143 0.3× 156 1.0× 119 0.8× 78 0.8× 95 1.0× 28 656
S Barocci Italy 16 129 0.3× 151 0.9× 60 0.4× 55 0.6× 71 0.7× 53 693
H Kameoka Japan 13 116 0.3× 90 0.6× 120 0.9× 40 0.4× 51 0.5× 64 506
Taiji Nozaki Japan 16 335 0.8× 303 1.9× 111 0.8× 16 0.2× 189 2.0× 61 922
Ramsès Wassef Canada 14 228 0.5× 57 0.4× 74 0.5× 40 0.4× 44 0.5× 31 610
H. Ishida Japan 13 287 0.7× 420 2.6× 126 0.9× 21 0.2× 70 0.7× 48 691
Neil Lempert United States 14 213 0.5× 198 1.2× 110 0.8× 109 1.1× 99 1.0× 48 638
Starzl Te United States 13 568 1.4× 214 1.3× 45 0.3× 31 0.3× 93 1.0× 36 898
W. Harmon United States 16 260 0.6× 403 2.5× 88 0.6× 83 0.9× 77 0.8× 33 803
A. Shaked United States 13 342 0.8× 77 0.5× 80 0.6× 46 0.5× 53 0.6× 28 819

Countries citing papers authored by Mark V. Jarowenko

Since Specialization
Citations

This map shows the geographic impact of Mark V. Jarowenko's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark V. Jarowenko with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark V. Jarowenko more than expected).

Fields of papers citing papers by Mark V. Jarowenko

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark V. Jarowenko. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark V. Jarowenko. The network helps show where Mark V. Jarowenko may publish in the future.

Co-authorship network of co-authors of Mark V. Jarowenko

This figure shows the co-authorship network connecting the top 25 collaborators of Mark V. Jarowenko. A scholar is included among the top collaborators of Mark V. Jarowenko based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark V. Jarowenko. Mark V. Jarowenko is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ahsan, Nasimul, Michael J. Holman, Mark V. Jarowenko, M.S. Razzaque, & Harold C. Yang. (2002). Limited Dose Monoclonal IL‐2R Antibody Induction Protocol after Primary Kidney Transplantation. American Journal of Transplantation. 2(6). 568–573. 42 indexed citations
2.
Jarowenko, Mark V., et al.. (2001). Incidence of erectile dysfunction and efficacy of sildenafil in the cardiac transplantation patient. The Journal of Heart and Lung Transplantation. 20(2). 246–246. 3 indexed citations
3.
McLaughlin, Patricia J., et al.. (1999). HUMAN RENAL CELL CANCER PROLIFERATION IN TISSUE CULTURE IS TONICALLY INHIBITED BY OPIOID GROWTH FACTOR. The Journal of Urology. 162(6). 2186–2191. 47 indexed citations
4.
Jarowenko, Mark V., et al.. (1998). A COMPARATIVE STUDY OF CONVENTIONAL AND MINIMALLY INVASIVE OPEN LIVING DONOR NEPHRECTOMY. Transplantation. 65(Supplement). 161–161. 4 indexed citations
5.
Sarosdy, Michael F., M’Liss A. Hudson, William J. Ellis, et al.. (1998). Improved Detection of Recurrent Bladder Cancer Using the Bard BTA stat Test. The Journal of Urology. 159(2S). 601–602. 11 indexed citations
6.
Sarosdy, Michael F., M’Liss A. Hudson, William J. Ellis, et al.. (1997). Improved detection of recurrent bladder cancer using the bard bta stat test. Urology. 50(3). 349–353. 165 indexed citations
7.
Sarosdy, Michael F., Ralph W. deVere White, Mark S. Soloway, et al.. (1995). Results of a Multicenter Trial using the BTA Test to Monitor for and Diagnose Recurrent Bladder Cancer. The Journal of Urology. 379–383. 9 indexed citations
8.
Sarosdy, Michael F., Ralph W. deVere White, Mark S. Soloway, et al.. (1995). Results of a Multicenter Trial using the BTA Test to Monitor for and Diagnose Recurrent Bladder Cancer. The Journal of Urology. 154(2). 379–384. 201 indexed citations
9.
Jarowenko, Mark V., et al.. (1990). Stone formation as a cause of allograft pancreatitis in the recipient of a combined kidney and pancreas transplant. Clinical Transplantation. 4(2). 117–119. 1 indexed citations
10.
Kahan, Barry D. & Mark V. Jarowenko. (1989). REPLY TO JADOUL AND HENE. Transplantation. 48(2). 359–359. 1 indexed citations
11.
Sieber, Paul, John A. Belis, Mark V. Jarowenko, & Thomas J. Rohner. (1988). Desmopressin Control of Surgical Hemorrhage Secondary to Prolonged Bleeding Time. The Journal of Urology. 139(5). 1066–1067. 4 indexed citations
12.
Jarowenko, Mark V., Stuart M. Flechner, Charles T. Van Buren, Marc I. Lorber, & Barry D. Kahan. (1987). Influence of Cyclosporine on Posttransplant Blood Pressure Response. American Journal of Kidney Diseases. 10(2). 98–103. 32 indexed citations
13.
Jarowenko, Mark V. & Stuart M. Flechner. (1985). Recipient Ureterocalycostomy in a Renal Allograft: Case Report of a Transplant Salvage. The Journal of Urology. 133(5). 844–845. 9 indexed citations
14.
Jarowenko, Mark V., Stuart M. Flechner, Carl M. Sandler, Charles T. Van Buren, & Barry D. Kahan. (1985). Salvage of Difficult Transplant Complications by Percutaneous Techniques. The Journal of Urology. 133(5). 840–843. 15 indexed citations
15.
Kahan, B D, et al.. (1985). Impact of Cyclosporine on Renal Transplant Practice at the University of Texas Medical School at Houston. American Journal of Kidney Diseases. 5(6). 288–295. 29 indexed citations
16.
Kahan, B D, et al.. (1984). Impact of mode of pretransplant loading with cyclosporine on the incidence of early rejection in haploidentical living related donor renal recipients.. PubMed. 16(6). 1619–23. 3 indexed citations
17.
Buren, David Van, Michael Ried, Sara Gibbons, et al.. (1984). The antagonistic effect of rifampin upon cyclosporine bioavailability.. PubMed. 16(6). 1642–5. 37 indexed citations
18.
Bd, Kahan, et al.. (1984). The value of serial serum trough cyclosporine levels in human renal transplantation.. PubMed. 16(5). 1195–9. 32 indexed citations
19.
Jarowenko, Mark V. & Alan H. Bennett. (1983). Use of single J urinary diversion stents in intestinal urinary diversion. Urology. 22(4). 369–370. 14 indexed citations
20.
Jarowenko, Mark V., Dale Buchbinder, & Dhiraj M. Shah. (1981). Effect of External Pressure on Axillofemoral Bypass Grafts. Annals of Surgery. 193(3). 274–276. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Paramit Chowdhury Breakdown of academic impact, for papers by S Barocci Breakdown of academic impact, for papers by H Kameoka Breakdown of academic impact, for papers by Taiji Nozaki Breakdown of academic impact, for papers by Ramsès Wassef Breakdown of academic impact, for papers by H. Ishida Breakdown of academic impact, for papers by Neil Lempert Breakdown of academic impact, for papers by Starzl Te Breakdown of academic impact, for papers by W. Harmon Breakdown of academic impact, for papers by A. Shaked
Rankless by CCL
2026